gamendazole and Polycystic-Kidney-Diseases

gamendazole has been researched along with Polycystic-Kidney-Diseases* in 2 studies

Other Studies

2 other study(ies) available for gamendazole and Polycystic-Kidney-Diseases

ArticleYear
The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
    American journal of physiology. Renal physiology, 2022, 10-01, Volume: 323, Issue:4

    Autosomal dominant polycystic kidney disease (ADPKD) is a debilitating renal neoplastic disorder with limited treatment options. It is characterized by the formation of large fluid-filled cysts that develop from kidney tubules through abnormal cell proliferation and cyst-filling fluid secretion driven by cAMP-dependent Cl

    Topics: Actins; Animals; Carboxylic Acids; Cell Proliferation; Cells, Cultured; Colforsin; Cyclin-Dependent Kinase 4; Cystic Fibrosis Transmembrane Conductance Regulator; Cysts; EGF Family of Proteins; Heat-Shock Proteins; Humans; Indazoles; Kidney; Mice; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant; Proto-Oncogene Proteins c-akt; Receptors, Cell Surface

2022
H2-gamendazole: a new therapeutic lead for the treatment of polycystic kidney disease.
    American journal of physiology. Renal physiology, 2022, 12-01, Volume: 323, Issue:6

    Topics: Humans; Indazoles; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant

2022